BLTE Stock BLTE is expected to report earnings to rise+1.32% to -25 cents per share on May 08

A.I.dvisor
at Tickeron.com
05/07/24
Loading...
BLTE - Belite Bio
Belite Bio Earnings Graph
Q1'24
Est.
$-0.25
Q4'23
Beat
by $0.05
Q3'23
Missed
by $0.08
Q2'23
Missed
by $0.03
Q1'23
Missed
by $0.13
The last earnings report on December 31 showed earnings per share of -25 cents, beating the estimate of -30 cents. P/B Ratio (14.245) is normal, around the industry mean (10.333). P/E Ratio (0.000) is within average values for comparable stocks, (113.052). BLTE's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.445). BLTE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (0.000) is also within normal values, averaging (208.102). With 35.63K shares outstanding, the current market capitalization sits at 1.29B.
View a ticker or compare two or three
BLTEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
12750 High Bluff Drive
Phone
+1 858 246-6240
Employees
20
Web
https://www.belitebio.com